Caszyme is a startup company founded in 2017, based in Vilnius, Lithuania. 

Caszyme aims to develop new discoveries, innovative applications and top-quality research in the field of CRISPR based Molecular Tools. Company seeks to create outstanding value for researchers and companies practicing gene-editing worldwide. 

Caszyme was founded by scientists which were first to demonstrate that CRISPR-Cas9 can be used to operate precise double strand breaks in DNA, thereby enabling a new era of gene editing. The founders have long time expertise on research of Cas9 and other CRISPR-Cas protein expression, purification and characterization, as well as bioinformatic analysis of CRISPR-Cas system.

Caszyme activities:

• Exploring new Cas Proteins for various applications.
• Providing research services for CRISPR applications 
• Developing and characterizing new CRISPR based Molecular Tools. 

Caszyme is located in the Sunrise Valley in Vilnius, where the 80% of all scientific potential in Lithuania is gathered, close to Life Science Center of Vilnius University, National Center for Physical and Technological Sciences and etc. Caszyme has facilities and laboratories equipped with new equipment for research and development and a team of well-trained employees, who are co-authors of top-level publications and patents related to CRISPR-Cas.